Effect of Aerobic Interval Training With Vitamin D Supplement on Functional Capacity and Perceived Myalgia
NCT ID: NCT04319289
Last Updated: 2020-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2020-01-12
2020-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistive Exercise Versus HIIT on Calcium and Vitamin D
NCT05795504
Effect of Aerobic Training Versus Resistance Training on Plasma Homocystiene in Diabetic Patients
NCT05845190
Aerobic and Strength Training With Caloric Restriction on Insulin Resistance in Obese Premenopausal Women
NCT03716336
Effect of Interval Training on Arterial Stiffness in Women With Hypertension
NCT04862754
A Low-fat Diet Combined With Moderate-intensity Aerobic Exercise Versus Low-fat Diet, Aerobic Exercise Alone on Dyslipidemia and Depression Status in Obese Patients
NCT04802525
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
They are assigned randomly into three groups:
* Group (A): included 15 patients who are participating in an aerobic interval training exercise program with vitamin D supplementation (cholecalciferol 400 IU/day).
* Group (B): included 15 patients who are receiving vitamin D supplementation only (cholecalciferol 400 IU/day).
* Group (C): included 15 patients who are participating in an interval training exercise program only.
The intervention will last for 12 weeks
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group (A)
Included 15 patients who are participating in an aerobic interval training exercise program with vitamin D supplementation (cholecalciferol 400 IU/day).
The aerobic interval training is conducted for one hour, three days per week on a total period of 12 weeks.
aerobic interval training and Vitamin D supplementation,
The participants in both groups A will be instructed to perform aerobic interval exercises at 70% maxHR for 5 minutes and then decrease activity to 50% for 5 minutes and repeat for the length of the activity (the training will be done by using bicycle ergometer(Biodex LBC, Biodex Inc., New York).• Before starting training ; Maximum heart rate calculated from the following equation: maxHR= 220-age .
* Duration: the first five to ten minutes of each session were dedicated to warming up exercise on the bicycle in the form of slow progression exercise (to decrease the risk of hypotension, musculoskeletal injury and cardiovascular complications), followed by the active phase of exercise for 40 min., and finally cooling down phase for ten minutes. with intensity and speed decreased gradually until reaching the resting HR
* Frequency: 3 days/week., for 12 weeks
Also all participants in this group are taking gne capsule containing (cholecalciferol 400 IU) every day .
Group (B)
Included 15 patients who are receiving vitamin D supplementation only . One capsule containing (cholecalciferol 400 IU) was taken every day for 12 weeks
Vitamin D supplementation only
One capsule containing (cholecalciferol 400 IU) was taken every day .
Group (c)
Included 15 patients who are participating in an aerobic interval training exercise program only. The aerobic interval training is conducted for one hour, three days per week on a total period of 12 weeks.
aerobic interval training only
The participants in group C will be instructed to perform aerobic interval exercises at 70% maxHR for 5 minutes and then decrease activity to 50% for 5 minutes and repeat for the length of the activity (the training will be done by using bicycle ergometer(Biodex LBC, Biodex Inc., New York).• Before starting training ; Maximum heart rate calculated from the following equation: maxHR= 220-age (Gellish ,2007).
* Duration: the first five to ten minutes of each session were dedicated to warming up exercise on the bicycle in the form of slow progression exercise (to decrease the risk of hypotension, musculoskeletal injury and cardiovascular complications), followed by the active phase of exercise for 40 min., and finally cooling down phase for ten minutes. with intensity and speed decreased gradually until reaching the resting heart rate (Broderick et al.,2014).
* Frequency: 3 days/week. The whole training lasting for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aerobic interval training and Vitamin D supplementation,
The participants in both groups A will be instructed to perform aerobic interval exercises at 70% maxHR for 5 minutes and then decrease activity to 50% for 5 minutes and repeat for the length of the activity (the training will be done by using bicycle ergometer(Biodex LBC, Biodex Inc., New York).• Before starting training ; Maximum heart rate calculated from the following equation: maxHR= 220-age .
* Duration: the first five to ten minutes of each session were dedicated to warming up exercise on the bicycle in the form of slow progression exercise (to decrease the risk of hypotension, musculoskeletal injury and cardiovascular complications), followed by the active phase of exercise for 40 min., and finally cooling down phase for ten minutes. with intensity and speed decreased gradually until reaching the resting HR
* Frequency: 3 days/week., for 12 weeks
Also all participants in this group are taking gne capsule containing (cholecalciferol 400 IU) every day .
Vitamin D supplementation only
One capsule containing (cholecalciferol 400 IU) was taken every day .
aerobic interval training only
The participants in group C will be instructed to perform aerobic interval exercises at 70% maxHR for 5 minutes and then decrease activity to 50% for 5 minutes and repeat for the length of the activity (the training will be done by using bicycle ergometer(Biodex LBC, Biodex Inc., New York).• Before starting training ; Maximum heart rate calculated from the following equation: maxHR= 220-age (Gellish ,2007).
* Duration: the first five to ten minutes of each session were dedicated to warming up exercise on the bicycle in the form of slow progression exercise (to decrease the risk of hypotension, musculoskeletal injury and cardiovascular complications), followed by the active phase of exercise for 40 min., and finally cooling down phase for ten minutes. with intensity and speed decreased gradually until reaching the resting heart rate (Broderick et al.,2014).
* Frequency: 3 days/week. The whole training lasting for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients' ages ranged from 30 -40 years.
* All patients have non specific muscle pain for more than 2 months.
* They have vitamin D deficiency.
* All patients have BMI from 25 to 34.9 kg/m2.
* All patients were clinically and medically stable when attending the study.
Exclusion Criteria
* Patients with diseases which affect vitamin D level as a history of rheumatic or metabolic bone diseases and diabetes.
* Patients taking drugs which affect vitamin D level as steroids and anticonvulsants drugs .
* Musculoskeletal disorders which may affect their physical ability to do the exercises.
30 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heba Ahmed Ali Abdeen
Assistant professor, Faculty of Physical Therapy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Physical Therapy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020HAAE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.